Skip to content
10-Q

Quarterly Report

LTS NUTRACEUTICALS, INC.

0001144204-11-063245

← back to feed
Filed
Nov 14, 2011 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2011 · Nov 14, 2011 42.1M sh
Stock Repurchased Q3 2011 · Sep 30, 2011 $65K
Stock Repurchased Q3 2011 · Sep 30, 2010 $0
Capex Q3 2011 · Sep 30, 2011 $72.58K
Capex Q3 2011 · Sep 30, 2010 $0
Operating Cash Flow Q3 2011 · Sep 30, 2011 −$2.02M
Operating Cash Flow Q3 2011 · Sep 30, 2010 −$311.24K
Cash And Equivalents Q3 2011 · Sep 30, 2011 $387K
Cash And Equivalents Q3 2011 · Dec 31, 2010 $53.86K
Cash And Equivalents Q3 2011 · Sep 30, 2010 $25.23K
Cash And Equivalents Q3 2011 · Dec 31, 2009 $31.46K
Stockholders Equity Q3 2011 · Sep 30, 2011 −$4.55M
Stockholders Equity Q3 2011 · Dec 31, 2010 −$1.54M
Current Liabilities Q3 2011 · Sep 30, 2011 $2.34M
Current Liabilities Q3 2011 · Dec 31, 2010 $564.66K
Total Liabilities Q3 2011 · Sep 30, 2011 $8.03M
Total Liabilities Q3 2011 · Dec 31, 2010 $1.88M
Current Assets Q3 2011 · Sep 30, 2011 $2.63M
Current Assets Q3 2011 · Dec 31, 2010 $330.4K
Total Assets Q3 2011 · Sep 30, 2011 $3.48M
Total Assets Q3 2011 · Dec 31, 2010 $344.38K
Sga Expense Q3 2011 · Sep 30, 2011 $908.5K
Sga Expense Q3 2011 · Sep 30, 2011 $2.23M
Sga Expense Q3 2011 · Sep 30, 2010 $217.09K
Sga Expense Q3 2011 · Sep 30, 2010 $530.82K
Net Income Q3 2011 · Sep 30, 2011 −$1.12M
Net Income Q3 2011 · Sep 30, 2011 −$2.96M
Net Income Q3 2011 · Sep 30, 2010 −$126.33K
Net Income Q3 2011 · Sep 30, 2010 −$471.24K
Operating Income Q3 2011 · Sep 30, 2011 −$704.31K
Operating Income Q3 2011 · Sep 30, 2011 −$2.14M
Operating Income Q3 2011 · Sep 30, 2010 −$79.85K
Operating Income Q3 2011 · Sep 30, 2010 −$363.44K
Gross Profit Q3 2011 · Sep 30, 2011 $478.6K
Gross Profit Q3 2011 · Sep 30, 2011 $668.12K
Gross Profit Q3 2011 · Sep 30, 2010 $173.09K
Gross Profit Q3 2011 · Sep 30, 2010 $472.58K
Cost Of Revenue Q3 2011 · Sep 30, 2011 $718.01K
Cost Of Revenue Q3 2011 · Sep 30, 2011 $1.09M
Cost Of Revenue Q3 2011 · Sep 30, 2010 $76.67K
Cost Of Revenue Q3 2011 · Sep 30, 2010 $525.08K